Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA* Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis

Documenti analoghi

• Enhancing the Protective Efficacy of Mycobacterium bovis BCG Vaccination against Tuberculosis by Boosting with the Mycobacterium tuberculosis Major Secretory Protein
  di: Horwitz, Marcus A., et al.
  Pubblicazione: (2005)
• A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
  di: Tullius, Michael V., et al.
  Pubblicazione: (2008)
• Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
  di: Horwitz, Marcus A., et al.
  Pubblicazione: (2000)
• σ(B)-and PrfA-Dependent Transcription of Genes Previously Classified as Putative Constituents of the Listeria monocytogenes PrfA Regulon
  di: Ollinger, Juliane, et al.
  Pubblicazione: (2008)
• Identification of a 25-kilodalton protein of Mycobacterium bovis BCG to distinguish BCG strains from Mycobacterium tuberculosis.
  di: Kumar, D, et al.
  Pubblicazione: (1996)